Publications: Dr Mangesh Thorat

Chougle Q, Chandra A, Thorat M, Hamed H, Kothari A ( 2024 ) . Audit on the use of core biopsy imprint cytology in a one stop Breast clinic . European Journal of Surgical Oncology vol. 50 , ( 2 )

Mathew G, Sohrabi C, Franchi T, Nicola M, Kerwan A, Agha R, Ekser B, McCaul J et al. ( 2023 ) . Preferred Reporting Of Case Series in Surgery (PROCESS) 2023 guidelines . International Journal of Surgery vol. 109 , ( 12 ) 3760 - 3769 .

Garg N, Thorat MA ( 2023 ) . Letter to the Editor: Cost‐Efficacy Analysis of Use of Frozen Section Histology for Margin Assessment During Breast Conservation Surgery in Breast Cancer Patients . World Journal of Surgery vol. 47 , ( 12 ) 3451 - 3452 .

Thorat MA ( 2023 ) . Multiclonality of ER expression in DCIS – Implications for clinical practice and future research . Oncotarget vol. 14 , ( 1 ) 719 - 720 .

McDermott KT, Noake C, Wolff R, Bauld L, Espina C, Foucaud J, Steindorf K, Thorat MA et al. ( 2023 ) . Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews . Frontiers in Digital Health vol. 5 ,

McDermott KT, Noake C, Wolff R, Espina C, Foucaud J, Steindorf K, Schüz J, Thorat MA et al. ( 2023 ) . Digital interventions to moderate alcohol consumption in young people: a Cancer Prevention Europe overview of systematic reviews . Frontiers in Digital Health vol. 5 ,

Sohrabi C, Mathew G, Maria N, Kerwan A, Franchi T, Agha RA, Bashashati M, Valmasoni M et al. ( 2023 ) . The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines . International Journal of Surgery vol. 109 , ( 5 ) 1136 - 1140 .

Li H, Madabhushi A, Badve S, Cuzick J, Thorat MA ( 2023 ) . P240 Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) as a prognostic and predictive factor in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial . The Breast vol. 68 ,

Garg N, Thorat MA, Deshpande A ( 2023 ) . P236 Immediate breast reconstruction as a day case procedure and impact of COVID-19 pandemic . The Breast vol. 68 ,

Garg N, Thorat MA ( 2023 ) . HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment! . Oncoscience vol. 10 , 1 - 3 .

Li H, Madabhushi A, Badve S, Cuzick J, Thorat MA ( 2023 ) . Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) as a prognostic and predictive factor in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial . BREAST . vol. 68 , S111 - S111 .

Garg N, Thorat MA, Deshpande A ( 2023 ) . Immediate breast reconstruction as a day case procedure and impact of COVID-19 pandemic . BREAST . vol. 68 , S109 - S109 .

Mathew G, Agha R, Group S, Albrecht J, Goel P, Mukherjee I, Pai P, D'Cruz AK et al. ( 2021 ) . STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery . International Journal of Surgery vol. 96 ,

Mathew G, Agha R, Group STROCSS, Albrecht J, Goel P, Mukherjee I, Pai P, D'Cruz AK et al. ( 2021 ) . STROCSS 2021: Strengthening The Reporting of Cohort, Cross-sectional and Case-control Studies in Surgery . International Journal of Surgery Open100430 - 100430 .

Agha R, Mathew G, Group STROCSS, Albrecht J, Goel P, Mukherjee I, Pai P, D'Cruz AK et al. ( 2021 ) . STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery . Annals of Medicine and Surgery103026 - 103026 .

Atakpa EC, Thorat MA, Cuzick J, Brentnall AR ( 2021 ) . Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review . Cochrane Database of Systematic Reviews vol. 2021 , ( 10 )

Thorat M ( 2021 ) . Delivering brief physical activity interventions in primary care: a systematic review of the prevalence, and factors associated with delivery, receipt, and patient receptivity . British Journal of General Practice

Thorat M, Cuzick J, Jones J, Levey P ( 2021 ) . Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial . Clinical Cancer Research

Lloyd KE, Hall LH, Ziegler L, Smith SG ( 2021 ) . Breast cancer worry in higher-risk women offered preventive therapy: a UK multicentre prospective study . Breast Cancer Research and Treatment vol. 188 , ( 3 ) 703 - 712 .

Thorat M, Levey PM, Jones LJ, Pinder SE, Bundred NJ, Fentiman IS, Cuzick J ( 2021 ) . Prognostic value of ER and PgR expression and the impact of multi-clonal expression for recurrence in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial . Clinical Cancer Research

Li H, Fu P, Toro P, Madabhushi A, Thorat M ( 2021 ) . Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) Density on H&E Images is Associated with Recurrence Risk in Ductal Carcinoma in Situ (DCIS) . MODERN PATHOLOGY . vol. 34 , 121 - 122 .

Agha RA, Sohrabi C, Mathew G, Franchi T, Kerwan A, O’Neill N, Group FTP, Thoma A et al. ( 2020 ) . The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines . International Journal of Surgery vol. 84 , 231 - 235 .

Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A, Group S, Thoma A, Beamish AJ et al. ( 2020 ) . The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines . International Journal of Surgery vol. 84 , 226 - 230 .

Li H, Bera K, Gilmore H, Zhang Z, Cuzick J, Thorat MA, Madabhushi A ( 2020 ) . Abstract P5-06-15: Computer extracted features of nuclear shape, orientation disorder and texture from H&E Whole slide images are associated with disease-free survival in ductal carcinoma in situ (DCIS) . Cancer Research . vol. 80 ,

Thorat M, Balasubramanian R ( 2019 ) . Breast cancer prevention in high risk women . Best Practice and Research: Clinical Obstetrics and Gynaecology

Agha R, Abdall-Razak A, Crossley E, Dowlut N, Iosifidis C, Mathew G ( 2019 ) . STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery . International Journal of Surgery vol. 72 , 156 - 165 .

Li H, Whitney J, Bera K, Gilmore H, Thorat M, Badve S, Madabhusi A ( 2019 ) . Quantitative nuclear histomorphometric features are predictive of Oncotype DX risk categories in Ductal Carcinoma In Situ: Preliminary Findings . Breast Cancer Research vol. 21 , ( 114 )

Dowling RJO, Sparano JA, Goodwin PJ, Bidard F-C, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M et al. ( 2019 ) . Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions . JNCI Cancer Spectrum vol. 3 , ( 4 )

Dowling RJO, Kalinsky K, Hayes DF, Bidard F-C, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M et al. ( 2019 ) . Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations . JNCI Cancer Spectrum vol. 3 , ( 4 )

Espina C, Bauld L, Bonanni B, Brenner H, Brown K, Dillner J, Kampman E, Nilbert M et al. ( 2019 ) . The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe . Tumori Journal030089161985186 - 030089161985186 .

THORAT MA ( 2019 ) . Liquid Biopsy for Cancer Diagnosis and Screening – The Promise and Challenges . Annals of Clinical Biochemistry

Allen N, Allen M, Ahmed K, Gomm J, Nelan R, Nagano A, Chelala C, Gadaleta E et al. ( 2019 ) . Defining molecular signatures to personalise management of patients with early breast cancer . CANCER RESEARCH . Conference: 2018 San Antonio Breast Cancer Symposium from: 04/12/2019 to: 08/12/2019 , vol. 79 ,

THORAT MA ( 2018 ) . Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study . Clinical Breast Cancer

Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler AJ, Orgill DP, Zhu H, Alsawadi A et al. ( 2018 ) . The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines . International Journal of Surgery vol. 60 , 132 - 136 .

THORAT MA, Agha RA, Borrelli M, Farwana R, Koshy K, Fowler AJ, Orgill DP, The PROCESS Group ( 2018 ) . The PROCESS 2018 Statement: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines . International Journal of Surgery vol. 60 , 279 - 282 .

Atakpa EC, Thorat MA, Cuzick J, Brentnall AR ( 2018 ) . Mammographic density, endocrine therapy and breast cancer risk: A prognostic and predictive biomarker review . Cochrane Database of Systematic Reviews vol. 2018 , ( 8 )

Thorat MA ( 2018 ) . Aspirin . Reference Module in Biomedical Sciences , Elsevier

Agha RA, Fowler AJ, Saeta A, Barai I, Rajmohan S, Orgill DP, Afifi R, Al-Ahmadi R et al. ( 2017 ) . Erratum to “Erratum to “The SCARE guidelines: Consensus-based surgical case report guidelines” [Int. J. Surg. 34 (2016) 180–186]” [Int. J. Surg. 36 (2016) 396], (S1743919116310305), (10.1016/j.ijsu.2016.11.021)) . International Journal of Surgery vol. 47 , 151 - 151 .

Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP, Pagano D, Pai PS, Basu S et al. ( 2017 ) . The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery . International Journal of Surgery vol. 46 , 198 - 202 .

Thorat MA, Cuzick J ( 2017 ) . Preventing invasive breast cancer using endocrine therapy . Breast

Oke A, Knox J, Tan J, Aigret B, Schmid P, Coleman RE, Cuzick J, Thorat MA ( 2017 ) . Barriers to recruitment from primary care into a trial in secondary care settings: experience from the feasibility study of IBIS-3 trial . TRIALS . Conference: ICTMC/SCT 2017 vol. 18 ,

Cuzick J ( 2017 ) . SA 4.3 Preventing invasive breast cancer using endocrine therapy . The Breast vol. 32 , s7 - s8 .

Thorat MA, Wagner S, Jones LJ, Levey PM, Bulka K, Hoff R, Sangale Z, II FDD et al. ( 2017 ) . Prognostic and predictive relevance of cell cycle progression (CCP) score in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial . CANCER RESEARCH . Conference: San Antonio Breast Cancer Symposium vol. 77 ,

Ussi AE, Rebolj M, Thorat MA, Bietrix F, Fauvel A, Hajdúch M, Hill C, Walker I et al. ( 2016 ) . Assessing opportunities for coordinated R&D in early cancer detection and management in Europe . International Journal of Cancer vol. 140 , ( 7 ) 1700 - 1701 .

Agha RA, Fowler AJ, Saeta A, Barai I, Rajmohan S, Orgill DP, Afifi R, Al-Ahmadi R et al. ( 2016 ) . “The SCARE guidelines: Consensus-based surgical case report guidelines” [Int. J. Surg. 34 (2016) 180–186]((2016) 34 (180–186)(S174391911630303X)(10.1016/j.ijsu.2016.08.014)) . International Journal of Surgery vol. 36 , 396 - 396 .

Agha RA, Fowler AJ, Rajmohan S, Barai I, Orgill DP, PROCESS Group ( 2016 ) . Preferred reporting of case series in surgery; the PROCESS guidelines . Int J Surg vol. 36 , ( Pt A ) 319 - 323 .

Agha RA, Fowler AJ, Saeta A, Barai I, Rajmohan S, Orgill DP, Afifi R, Al-Ahmadi R et al. ( 2016 ) . The SCARE Statement: Consensus-based surgical case report guidelines . International Journal of Surgery vol. 34 , 180 - 186 .

THORAT MA ( 2016 ) . Individualised benefit–harm balance of aspirin as primary prevention measure – a good proof-of-concept, but could have been better… . BMC Medicine

Guerrieri-Gonzaga A, Sestak I, Lazzeroni M, Serrano D, Rotmensz N, Cazzaniga M, Varricchio C, Thorat MA et al. ( 2016 ) . Benefit of low-dose tamoxifen in a large, single-institution cohort of high-risk ER-positive DCIS . CANCER RESEARCH . Conference: AACR Annual Meeting vol. 76 ,

Thorat MA ( 2016 ) . A major flaw in "awareness of breast cancer and barriers to breast screening uptake in Bangladesh: A population based survey" . Maturitas vol. 88 , 45 - 45 .

Thorat MA, Wagner S, Jones LJ, Levey PM, Bulka K, Hoff R, Sangale Z, II FDD et al. ( 2016 ) . Prognostic and predictive relevance of HER2 status in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial . CANCER RESEARCH . vol. 76 ,

Thorat MA, Jones LJ, Levey PM, Elia G, Evagora CA, Bundred NJ, Fentiman IS, Forbes JF et al. ( 2016 ) . Prognostic role and impact of multi-clonal ER and PgR expression in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial . CANCER RESEARCH . vol. 76 ,

DeCensi A, Thorat MA, Bonanni B, Smith SG, Cuzick J ( 2015 ) . Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake . Ecancermedicalscience vol. 9 ,

Cuzick J, Sestak I, Thorat MA ( 2015 ) . Impact of preventive therapy on the risk of breast cancer among women with benign breast disease . The Breast vol. 24 , ( Suppl 2 ) s51 - s55 .

Pathmarajah P, Shah K, Taghipour K, Ramachandra S, Thorat MA, Chaudhry Z, Patkar V, Peters F et al. ( 2015 ) . Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK . International Journal of Surgery Case Reports vol. 16 , 77 - 80 .

Thorat MA ( 2015 ) . Sentinel lymph node assessment in breast cancer patients receiving neo‐adjuvant chemotherapy: to biopsy before or after? . International Journal of Cancer vol. 138 , ( 2 ) 267 - 270 .

Cuzick J, Cuschieri K, Denton K, Hopkins M, Thorat MA, Wright C, Cubie H, Moore C et al. ( 2015 ) . Performance of the Xpert HPV assay in women attending for cervical screening . Tumour Virus Research vol. 1 , 32 - 37 .

Cuzick J, Thorat M ( 2015 ) . PG 6.02 Preventing invasive breast cancer in women at high risk based on benign/in situ pathology . The Breast . vol. 24 ,

Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ et al. ( 2015 ) . Estimates of benefits and harms of prophylactic use of aspirin in the general population . Ann Oncol vol. 26 , ( 1 ) 47 - 57 .

Cuzick J, Thorat MA ( 2014 ) . PSA testing for prostate cancer screening – Authors' reply . The Lancet Oncology vol. 16 , ( 1 )

Thorat MA, Cuzick J ( 2014 ) . Reply to the Letter to the Editor "The harms of low-dose aspirin prophylaxis are overstated" by P. Elwood and G. Morgan . Annals of Oncology

Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, Eeles RA, Ford LG et al. ( 2014 ) . Prevention and early detection of prostate cancer . Lancet Oncol vol. 15 , ( 11 ) e484 - e492 .

Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ et al. ( 2014 ) . Estimates of benefits and harms of prophylactic use of aspirin in the general population . Annals of Oncology

Vasiljevic N, Ahmad A, Thorat M, Fisher G, Berney D, Moller H, Foster C, Cuzick J et al. ( 2014 ) . DNA methylation gene-based models indicating independent poor outcome in prostate cancer . BMC Cancer vol. 14 , ( 1 )

Cuzick J, Thorat MA ( 2014 ) . Preface .

Thorat M, Cuzick J ( 2014 ) . Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population . European Journal of Epidemiology vol. 30 , ( 1 ) 5 - 18 .

Thorat MA, Cuzick J ( 2013 ) . Role of aspirin in cancer prevention . Curr Oncol Rep vol. 15 , ( 6 ) 533 - 540 .

Gökmen-Polar Y, Thorat MA, Sojitra P, Saxena R, Badve S ( 2013 ) . FOXP3 expression and nodal metastasis of breast cancer . Cellular Oncology vol. 36 , ( 5 ) 405 - 409 .

Vasiljević N, Ahmad AS, Beesley C, Thorat MA, Fisher G, Berney DM, Møller H, Yu Y et al. ( 2013 ) . Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer . Prostate Cancer Prostatic Dis vol. 16 , ( 1 ) 35 - 40 .

Sainsbury R, Loddo M, Proctor I, Stoeber K, Williams G, Thorat M, Cuzick J ( 2012 ) . Abstract PD04-08: Cell cycle algorithm correlates with grade of DCIS and p53 status, allows elimination of ‘intermediate grade’ disease and gives clinically meanignful information . Cancer Research . vol. 72 ,

Duchnowska R, Jassem J, Goswami CP, Gokmen-Polar Y, Li L, Thorat MA, Flores N, Hua E et al. ( 2012 ) . 13-gene signature to predict rapid development of brain metastases in patients with HER2-positive advanced breast cancer . Journal of Clinical Oncology vol. 30 , ( 15_suppl ) 505 - 505 .

Duchnowska R, Jassem J, Goswami CP, Gokmen-Polar Y, Li L, Thorat MA, Flores N, Hua E et al. ( 2012 ) . 13-gene signature to predict rapid development of brain metastases in patients with HER2-positive advanced breast cancer . JOURNAL OF CLINICAL ONCOLOGY . vol. 30 ,

Schneider BP, Radovich M, Hancock B, Kassem N, Sledge G, Nielsen KV, Thorat M, Mehta R et al. ( 2012 ) . <i>VEGFA</i> Amplification/Deletion in Human Breast Tumors . MODERN PATHOLOGY . vol. 25 , 65A - 65A .

Cheol Kim D, Thorat MA, Lee MR, Cho SH, Vasiljević N, Scibior-Bentkowska D, Wu K, Ahmad AS et al. ( 2012 ) . Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes . Cancer Biomark vol. 11 , ( 2-3 ) 75 - 88 .

Thorat MA ( 2012 ) . Tackling breast cancer in India . The Lancet vol. 379 , ( 9834 ) 2340 - 2341 .

Duchnowska R, Jassem J, Szutowicz E, Biernat W, Jankowski T, Och W, Staszkiewicz R, Chudzik M et al. ( 2011 ) . RAD51 and brain metastases (BM) in patients (pts) with HER2+ breast cancer . Journal of Clinical Oncology . vol. 29 , 634 - 634 .

Sojitra PM, Thorat M, Jain RK, Mehta R, Badve S ( 2011 ) . Regulatory T-Cells in Breast Cancer Sentinel Nodes: FOXP3 Expression Analysis . MODERN PATHOLOGY . vol. 24 , 64A - 64A .

Vasiljević N, Wu K, Brentnall AR, Kim DC, Thorat MA, Kudahetti SC, Mao X, Xue L et al. ( 2011 ) . Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing . Dis Markers vol. 30 , ( 4 ) 151 - 161 .

Duchnowska R, Jassem J, Szutowicz E, Biernat W, Jankowski T, Och W, Staszkiewicz R, Chudzik M et al. ( 2011 ) . RAD51 and brain metastases (BM) in patients (pts) with HER2+breast cancer . JOURNAL OF CLINICAL ONCOLOGY . vol. 29 ,

Ademuyiwa FO, Miller A, O'Connor T, Edge SB, Thorat MA, Sledge GW, Levine E, Badve S ( 2011 ) . The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort . Breast Cancer Research and Treatment vol. 126 , ( 3 ) 797 - 802 .

Thorat MA, Thorat PM, Vaidya HJ, Vaidya JS ( 2010 ) . Analysis of temporal trends in the BMJ archive . The BMJ vol. 341 , ( oct21 2 )

Appaiah H, Bhat-Nakshatri P, Mehta R, Thorat M, Badve S, Nakshatri H ( 2010 ) . ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer . Cancer Biol Ther vol. 10 , ( 6 ) 600 - 614 .

Badve SS, Li L, Thorat MA, Gagnon RC, Ellis CE, O'Shaughnessy J, Blackwell KL, Baselga J et al. ( 2010 ) . Differential gene expression analysis and correlation with outcome in HER2-positive metastatic breast cancer treated with HER2-targeted therapy . Journal of Clinical Oncology . vol. 28 , 1036 - 1036 .

Ademuyiwa FO, Miller A, Edge SB, Thorat MA, Sledge GW, Badve SS ( 2010 ) . The effects of Oncotype DX recurrence scores on chemotherapy receipt in a multi-institutional breast cancer cohort . Journal of Clinical Oncology . vol. 28 , 669 - 669 .

Schneider BP, Radovich M, Hancock BA, Kassem N, Vance GH, Sledge GW, Nielsen KV, Müller S et al. ( 2010 ) . VEGFA amplification/deletion in human breast tumors . Journal of Clinical Oncology . vol. 28 , e21017 - e21017 .

Badve S, Collins NR, Bhat-Nakshatri P, Turbin D, Leung S, Thorat M, Dunn SE, Geistlinger TR et al. ( 2010 ) . Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications . Am J Pathol vol. 176 , ( 5 ) 2139 - 2149 .

Gokmen-Polar Y, Mehta R, Tuzmen S, Mousses S, Thorat MA, Sanders KL, Turbin D, Leung S et al. ( 2010 ) . Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes . Breast Cancer Res Treat. vol. 124 , ( 2 ) 327 - 335 .

ADEMUYIWA F, THORAT M, JAIN R, NAKSHATRI H, BADVE S ( 2010 ) . Expression of Forkhead- box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores . Mod Pathol. vol. 23 , ( 2 ) 270 - 275 .

Jain RK, Thorat MA, Mehta R, Polar Y, Morimiya A, Sweeney C, Beck S, Ulbright TM et al. ( 2010 ) . Gene Expression Profiles of Classical and Spermatocytic Seminoma . MODERN PATHOLOGY . vol. 23 , 198A - 198A .

McCune K, Mehta R, Thorat MA, Badve S, Nakshatri H ( 2010 ) . Loss of ER alpha and FOXA1 expression in a progression model of luminal type breast cancer: Insights from PyMT transgenic mouse model . Oncol Rep. vol. 24 , ( 5 ) 1233 - 1239 .

McCune K, Mehta R, Thorat MA, Badve S, Nakshatri H ( 2010 ) . Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: Insights from PyMT transgenic mouse model . ONCOLOGY REPORTS vol. 24 , ( 5 ) 1233 - 1239 .

MCCUNE K, BHAT-NAKSHATRI P, THORAT M, NEPHEW K, BADVE S, NAKSHATRI H ( 2010 ) . Prognosis of Hormone-Dependent Breast Cancers: Implications of the Presence of Dysfunctional Transcriptional Networks Activated by Insulin via the Immune Transcription Factor T-bet . Cancer Res. vol. 70 , ( 2 ) 685 - 696 .

Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S ( 2010 ) . Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment . Breast Cancer Research and Treatment vol. 123 , ( 1 ) 97 - 108 .

Vaidya JS, Baldassarre G, Thorat MA, Massarut S ( 2010 ) . Role of Glucocorticoids in Breast Cancer . Current Pharmaceutical Design vol. 16 , ( 32 ) 3593 - 3600 .

Badve S, Shen C, Thorat M, Li L, Gagnon R, Koehler M, Ellis C, O'Shaughnessy J et al. ( 2009 ) . Identification of gene expression profiles that predict response to HER2-targeted therapy . EJC SUPPLEMENTS . vol. 7 , 5 - 5 .

Ademuyiwa FO, Thorat M, Nakshatri H, Badve S ( 2009 ) . Correlation of FOXA1 expression with Oncotype Dx recurrence scores . Journal of Clinical Oncology . vol. 27 , 11058 - 11058 .

McCune K, Thorat M, Badve S, Nakshatri H ( 2009 ) . A transgenic model for dietary intervention/chemoprevention strategies for metastatic breast cancer . ANN SURG ONCOL . vol. 16 , 45 - 45 .

McCune KR, Bhat-Nakshatri P, Thorat M, Badve S, Nakshatri H ( 2009 ) . Control of luminal type A intrinsic subtype enriched transcription factor network by insulin: implications of diabetes on breast cancer classification . CANCER RESEARCH . vol. 69 , 213S - 214S .

McCune K, Bhat-Nakshatri P, Thorat M, Badve S, Nakshatri H ( 2009 ) . Control of luminal type A intrinsic subtype enriched transcription factor network by insulin: implications of diabetes on breast cancer classification . Cancer Research . vol. 69 ,

Duchnowska R, Jassem J, Shen C, Thorat M, Li L, Morimiya A, Zhao Q, Biernat W et al. ( 2009 ) . Molecular characteristics of matched brain metastasis (BM) versus the primary breast cancer (PBC) . CANCER RESEARCH . vol. 69 , 164S - 164S .

THORAT M, MEHROTRA S, MORIMIYA A, al. E ( 2009 ) . COX-2 Expression Does Not Correlate with Microvessel Density in Breast Cancer . Pathobiology journal of immunopathology molecular and cellular biology vol. 76 , ( 1 ) 39 - 44 .

THORAT M ( 2009 ) . Comment on "Dynamic response to heat--a novel physical characteristic of breast cancer" . International journal of surgery vol. 7 , ( 2 )

HAMMOUD Z, BADVE S, ZHAO Q, LI L, SAXENA R, THORAT M, MORIMIYA A, RIEGER K et al. ( 2009 ) . Differential gene expression profiling of esophageal adenocarcinoma . J Thorac Cardiovasc Surg vol. 137 , ( 4 ) 829 - 834 .

THORAT M, ADEMUYIWA F, NAKSHATRI H, al. E ( 2009 ) . Expression of FOXA1, Estrogen Receptor Associated Transcription Factor, Correlates with Oncotype Dx Recurrence Score . Conference: LABORATORY INVESTIGATION vol. 89 , 72A - 72A .

AL-AZZAWI H, PITT H, SWARTZ-BASILE D, WANG S, DALBEC K, THORAT M, ZYROMSKI N ( 2009 ) . Obesity downregulates innate and adaptive immunity genes in the pancreatic cancer microenvironment . Conference: 95th Annual Clinical Congress of the American-College-of-Surgeons/64th Annual Sessions of the Owen H Wangensteen Forum on Fundamental Surgical Problems vol. 209 , S118 - S119 .

Al-Azzawi H, Swartz-Basile D, Wang S, Dalbec K, Thorat M, Pitt H, Zyromski N ( 2009 ) . Obesity promotes differential gene expression in pancreatic cancer . CANCER RESEARCH . vol. 69 ,

Thorat MA, Rangole A, Nadkarni MS, Parmar V, Badwe RA ( 2008 ) . Revision surgery for breast cancer: Single-institution experience . Cancer vol. 113 , ( 8 SUPPL. ) 2347 - 2352 .

Badve S, Thorat M, Reis-Filho J ( 2008 ) . Cytoplasmic expression of ALDH1 correlates with breast cancer subtypes . HISTOPATHOLOGY . vol. 53 , 26 - 26 .

Resetkova E, Thorat M, Badve S ( 2008 ) . Expression of ALDH1 (putative cancer stem cell marker) does not correlate with response to neoadjuvant chemotherapy (NACT) in breast carcinoma . HISTOPATHOLOGY . vol. 53 , 59 - 60 .

Thorat MA, Badve S ( 2008 ) . Estrogen- and progesterone-receptor status in breast cancer: Immunohistochemistry and quantitative reverse transcription-polymerase chain reaction assays show equivalency . American Journal of Hematology/ Oncology vol. 7 , ( 9 )

Coates RJ, Khoury MJ, Gwinn M ( 2008 ) . Five Genetic Variants Associated with Prostate Cancer . New England Journal of Medicine vol. 358 , ( 25 ) 2738 - 2741 .

Janssens ACJW, van Duijn CM ( 2008 ) . Five genetic variants associated with prostate cancer . New England Journal of Medicine vol. 358 , ( 25 )

Duchnowska R, Jassem J, Thorat MA, Morimiya A, Sledge GW, Li L, Biernat W, Szczylik C et al. ( 2008 ) . Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts) . Journal of Clinical Oncology . vol. 26 , 1019 - 1019 .

Thorat MA, Saxena R, Badve SS ( 2008 ) . Regulatory T cells (T-Regs) in breast cancer sentinel nodes (SN): FOXP3 expression analysis . Journal of Clinical Oncology . vol. 26 , 22175 - 22175 .

THORAT M, TURBIN D, MORIMIYA A, al. E ( 2008 ) . Amplified in breast cancer 1 expression in breast cancer . Histopathology vol. 53 , ( 6 ) 634 - 641 .

HAN-COCK B, RADOVICH M, BADVE S, THORAT M, AZZOUZ F, SCHNEIDER B ( 2008 ) . Association of single nucleotide polymorphisms in angiogenesis genes with expression of VEGF and VEGFR-2 in breast carcinoma . Conference: Proceedings of the American Association for Cancer Research Annual Meeting vol. 49 ,

GOKMEN-POLAR Y, THORAT M, TURBIN D, TUZMEN S, LEUNG S, HUNTSMAN D, BADVE S, SLEDGE G ( 2008 ) . Differential subcellular expression of protein kinase C betaII in breast cancer: Correlation with breast cancer subtypes . American Association for Cancer Research

Marchio C, Thorat M, Morimiya A, Savage K, Nakshatri H, Reis-Filho J, Badve S ( 2008 ) . FOXA1: A prognostic and luminal subtype a marker in breast cancer . MODERN PATHOLOGY . vol. 21 , 45A - 45A .

THORAT M ( 2008 ) . Five genetic variants associated with prostate cancer . N Engl J Med. vol. 358 , ( 25 ) 2740 - 2740 .

THORAT M, MARCHIO C, MORIMIYA A, al. E ( 2008 ) . Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis . Journal of Clinical Pathology vol. 61 , ( 3 ) 327 - 332 .

Duchnowska R, Jassem J, Thorat MA, Morimiya A, Sledge GW, Li L, Biernat W, Szczylik C et al. ( 2008 ) . Gene expression analysis for prediction of early brain metastasis (BM) in HER2-positive (HER2+) breast cancer patients (pts) . JOURNAL OF CLINICAL ONCOLOGY . vol. 26 ,

THORAT M, THORNTON H ( 2008 ) . MRI breast screening . The Lancet vol. 371 , ( 9622 )

THORAT M, MORIMIYA A, MEHROTRA S, al. E ( 2008 ) . Prostanoid receptor EP1 expression in breast cancer . Modern Pathology vol. 21 , ( 1 ) 15 - 21 .

Thorat MA, Saxena R, Badve SS ( 2008 ) . Regulatory T cells (T-Regs) in breast cancer sentinel nodes (SN): FOXP3 expression analysis . JOURNAL OF CLINICAL ONCOLOGY . vol. 26 ,

THORAT M, RANGOLE A, NADKARNI M, al. E ( 2008 ) . Revision Surgery for Breast Cancer: Single-Institution Experience . vol. 113 , ( Supplement 8 ) 2347 - 2352 .

THORAT M ( 2008 ) . What caused the decline in US breast cancer incidence? . Nat Clin Pract Oncol. vol. 5 , ( 6 ) 314 - 315 .

Thorat M, Morimiya A, Sledge G, Badve S ( 2007 ) . Characterization of estrogen receptor positive breast cancers: gene expression analysis of archived tumours . BREAST CANCER RESEARCH AND TREATMENT . vol. 106 , S243 - S243 .

Thorat MA, Badve S ( 2007 ) . Prognostic factors in invasive breast carcinoma: Do new molecular techniques/profiling add significantly to traditional histological factors? . Current Diagnostic Pathology vol. 13 , ( 2 ) 116 - 125 .

Basu S, Nair N, Thorat M, Shet T ( 2007 ) . Uptake characteristics of FDG in multiple juvenile cellular fibroadenomata of the breast: FDG-PET and histopathologic correlation . Clin Nucl Med vol. 32 , ( 3 ) 203 - 204 .

BADVE S, TURBIN D, THORAT M, Morimaya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG et al. ( 2007 ) . FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival . Clinical Cancer Research vol. 13 , ( 15 ) 4415 - 4421 .

THORAT M ( 2007 ) . Gene-signature-based prognostic tools in breast cancer: not yet . vol. 369 , ( 9571 ) 1428 - 1428 .

THORAT M, PARMAR V, NADKARNI M, al. E ( 2007 ) . Radiation therapy for ductal carcinoma in situ: Is it really worth it? . vol. 25 , ( 4 ) 461 - 462 .

THORAT M ( 2007 ) . Should we undertake an MRI breast screening trial? . vol. 370 , ( 9603 ) 1902 - 1902 .

Thorat M ( 2006 ) . Tuning into the genetic orchestra using microarrays: limitations of DNA microarrays in clinical practice - Response . NAT CLIN PRACT ONCOL vol. 3 , ( 12 )

Thorat M ( 2006 ) . Tuning into the genetic orchestra using microarrays: limitations of DNA microarrays in clinical practice . Nat Clin Pract Oncol vol. 3 , ( 12 )

Thorat M ( 2006 ) . Trastuzumab for early breast cancer . Lancet vol. 367 , ( 9505 )

Thorat MA ( 2006 ) . Are there distinct lymphatic flow patterns in the breast? . Med. Hypotheses vol. 66 , ( 5 ) 1040 - 1041 .

THORAT M, DATAR R, JOSHI N ( 2006 ) . Cancer immunotherapeutics: Raising the ante . vol. 19 , ( 3 ) 140 - 150 .

BADWE R, D'CRUZ A, MISTRY R, al. E ( 2006 ) . Developing countries: An evolving opportunity for oncologic research . vol. 30 , ( 7 ) 1173 - 1176 .

THORAT M ( 2006 ) . Medical research in India . vol. 368 , ( 9536 ) 643 - 644 .

Kida Y, Thorat MA, Badwe RA ( 2005 ) . Autoantibodies in prostate cancer [2] . New England Journal of Medicine vol. 353 , ( 26 ) 2815 - 2816 .

Thorat MA, Badwe RA ( 2005 ) . Autoantibodies in prostate cancer . N Engl J Med vol. 353 , ( 26 ) 2815 - 2817 .

THORAT M, BADWE R ( 2005 ) . Autoantibodies in prostate cancer . vol. 353 , ( 26 ) 2816 - 2816 .

BADWE R, THORAT M ( 2005 ) . Does primary tumor location have prognostic significance in operable breast cancer? . vol. 2 , ( 8 ) 396 - 397 .

THORAT MA ( 2005 ) . Herceptin in early breast cancer: a call for judicious use . vol. 18 , ( 6 ) 315 - 317 .

THORAT M, THORAT P ( 2005 ) . Privately versus publicly managed primary healthcare . vol. 18 , ( 5 ) 274 - 275 .

Thorat M ( 2004 ) . Optimum cancer care--an unaffordable goal? . Lancet Oncol vol. 5 , ( 9 )

Badwe RA, Thorat MA, Parmar VV, De Salvo GL, Del Bianco P, Zavagno G, Munster AM, McMasters KM et al. ( 2003 ) . Sentinel-Node Biopsy in Breast Cancer [1] (multiple letters) . New England Journal of Medicine vol. 349 , ( 20 ) 1968 - 1971 .

BADWE R, THORAT M, PARMAR V ( 2003 ) . Sentinel-node biopsy in breast cancer . vol. 349 , ( 20 ) 1968 - 1968 .

Badwe RA, Thorat MA, Havaldar RW, Komorowski AL, Wysocki W, Somlo G, Levitt SH, Fisher B et al. ( 2002 ) . Radical and simple mastectomy [3] multiple letters . New England Journal of Medicine vol. 347 , ( 26 ) 2170 - 2171 .

Somlo G ( 2002 ) . Radical and simple mastectomy . N Engl J Med vol. 347 , ( 26 ) 2170 - 2171 .

BADWE R, THORAT M, HAVALDAR R ( 2002 ) . Radical and simple mastectomy . vol. 347 , ( 26 ) 2170 - 2170 .